Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Can Netflix's Revenue Really Keep Up With Its Content Budget?
Can Netflix's Revenue Really Keep Up With Its Content Budget?
Netflix (NASDAQ: NFLX) gave investors a sneak peek of what's to come in 2018 when it released its third-quarter earnings last week. The streaming video company plans to spend between $7 billion....
What Procter & Gamble Co. Has to Say About Its Growth Slowdown
What Procter & Gamble Co. Has to Say About Its Growth Slowdown
Procter & Gamble (NYSE: PG) investors are hoping that slow and steady wins the race. The consumer-products giant recently announced earnings results that included weaker sales growth. But....
Trivago Still Presses for Maximum Growth
Trivago Still Presses for Maximum Growth
The key to success in many industries is to grow as quickly as possible to stay ahead of the competition. For online travel company Trivago (NASDAQ: TRVG), the presence of large competitors has....
Trivago Still Presses for Maximum Growth
Trivago Still Presses for Maximum Growth
The key to success in many industries is to grow as quickly as possible to stay ahead of the competition. For online travel company Trivago (NASDAQ: TRVG), the presence of large competitors has....
Trivago Still Presses for Maximum Growth
Trivago Still Presses for Maximum Growth
The key to success in many industries is to grow as quickly as possible to stay ahead of the competition. For online travel company Trivago (NASDAQ: TRVG), the presence of large competitors has....
Under Activist Investor Pressure, Hudson's Bay Sells Lord & Taylor Flagship Store
Under Activist Investor Pressure, Hudson's Bay Sells Lord & Taylor Flagship Store
Multinational retail giant Hudson's Bay (TSX: HBC) has experienced another round of upheaval in the past week. Last Friday, the company revealed that its CEO will step down at the end of the....
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. (NASDAQ: PCAR) reported strong results for its third quarter on Oct. 24. Revenue increased 19% and net income was up 16%, with both numbers even coming in ahead of Wall Street analyst....
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. (NASDAQ: PCAR) reported strong results for its third quarter on Oct. 24. Revenue increased 19% and net income was up 16%, with both numbers even coming in ahead of Wall Street analyst....
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. Keeps Cruising, but the Market's Worried About Something
PACCAR Inc. (NASDAQ: PCAR) reported strong results for its third quarter on Oct. 24. Revenue increased 19% and net income was up 16%, with both numbers even coming in ahead of Wall Street analyst....
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
Ever since the unveiling, many have been balking at the $1,000 starting price tag for Apple's (NASDAQ: AAPL) forthcoming iPhone X. At a time when smartphone commoditization already has a firm grip....
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
Ever since the unveiling, many have been balking at the $1,000 starting price tag for Apple's (NASDAQ: AAPL) forthcoming iPhone X. At a time when smartphone commoditization already has a firm grip....
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
Ever since the unveiling, many have been balking at the $1,000 starting price tag for Apple's (NASDAQ: AAPL) forthcoming iPhone X. At a time when smartphone commoditization already has a firm grip....
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
More Evidence That Apple's $1,150 iPhone X Will Sell Well -- if Apple Can Build Them
Ever since the unveiling, many have been balking at the $1,000 starting price tag for Apple's (NASDAQ: AAPL) forthcoming iPhone X. At a time when smartphone commoditization already has a firm grip....
This Marijuana Stock, With Its Eggs in 1 Basket, Popped 14% Last Week
This Marijuana Stock, With Its Eggs in 1 Basket, Popped 14% Last Week
When it comes to the markets' fastest growing industries, investors would have a hard time finding a group of stocks growing quicker than marijuana. According to a report from Marijuana Business....
3 Stocks to Buy for the Next Generation
3 Stocks to Buy for the Next Generation
Cutting-edge technology could make ABB Ltd. (NYSE: ABB), Illumina (NASDAQ: ILMN), and TransEnterix (NYSEMKT: TRXC) smart stocks for people to buy and hold for the long haul. Our Motley Fool....
3 Stocks to Buy for the Next Generation
3 Stocks to Buy for the Next Generation
Cutting-edge technology could make ABB Ltd. (NYSE: ABB), Illumina (NASDAQ: ILMN), and TransEnterix (NYSEMKT: TRXC) smart stocks for people to buy and hold for the long haul. Our Motley Fool....
3 Stocks to Buy for the Next Generation
3 Stocks to Buy for the Next Generation
Cutting-edge technology could make ABB Ltd. (NYSE: ABB), Illumina (NASDAQ: ILMN), and TransEnterix (NYSEMKT: TRXC) smart stocks for people to buy and hold for the long haul. Our Motley Fool....

	 
BASTIDE : Avis de Réunion de l'Assemblée générale mixte du 30 novembre 2017
BASTIDE : Avis de Réunion de l'Assemblée générale mixte du 30 novembre 2017
BASTIDE LE CONFORT MEDICAL Société Anonyme au capital de 3.303.261 euros Siège social : 12, avenue de la Dame, Zone euro 2000 30132 Caissargues 305 635 039 RCS NIMES AVIS DE....
1 Small-Cap Biotech Stock to Buy Right Now
1 Small-Cap Biotech Stock to Buy Right Now
Enzymes. You may not realize it, but they're pretty important to daily life. Your high-efficiency, phosphate-free laundry detergent that removes even the most stubborn stains in cold water? That's....
Better Buy: Johnson & Johnson vs. Pfizer
Better Buy: Johnson & Johnson vs. Pfizer
They're two of the oldest, largest, and most respected healthcare companies around. But one has made investors much happier than the other in recent years. Johnson & Johnson (NYSE: JNJ) stock....
Better Buy: Johnson & Johnson vs. Pfizer
Better Buy: Johnson & Johnson vs. Pfizer
They're two of the oldest, largest, and most respected healthcare companies around. But one has made investors much happier than the other in recent years. Johnson & Johnson (NYSE: JNJ) stock....
3 Things to Watch When ConocoPhillips Reports Q3 Earnings
3 Things to Watch When ConocoPhillips Reports Q3 Earnings
Oil and gas investors, hold your breath. Q3 2017 earnings in the energy sector are right around the corner, and one of the first companies to report is ConocoPhillips (NYSE: COP), the largest....
HP's Plans for 3D Metal Printing Could be a Game Changer
HP's Plans for 3D Metal Printing Could be a Game Changer
HP (NYSE: HPQ) CEO Dion Weisler recently revealed that his company planned to launch next-gen 3D printers that could produce metal objects. Weisler didn't reveal much else about the technology or....
Is Pfizer Inc. a Buy?
Is Pfizer Inc. a Buy?
Pfizer Inc. (NYSE: PFE) shares have risen around 12% this year, in step with the iShares US Pharmaceuticals index. With talk of another spinoff and strong sales growth, this big pharma stock looks....
Is Pfizer Inc. a Buy?
Is Pfizer Inc. a Buy?
Pfizer Inc. (NYSE: PFE) shares have risen around 12% this year, in step with the iShares US Pharmaceuticals index. With talk of another spinoff and strong sales growth, this big pharma stock looks....